Clinical Trial Update: Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety of FURESTEM-CD injections in adults with moderate to severe plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• FURESTEM-CD Inj. (FURESTEM-CD)

Snippet

Sponsor: Kang Stem Biotech Co., Ltd. | Conditions: Psoriasis | Phase 1 | Status: UNKNOWN